Cargando…
Glucocorticoids Antagonize Ap-1 by Inhibiting the Activation/Phosphorylation of Jnk without Affecting Its Subcellular Distribution
The immunosuppressive and antiinflammatory actions of glucocorticoid hormones are mediated by their transrepression of activating protein-1 (AP-1) and nuclear factor-kappa B (NFκB) transcription factors. Inhibition of the c-Jun NH(2)-terminal kinase (JNK) signaling pathway, the main mediator of AP-1...
Autores principales: | González, María Victoria, Jiménez, Benilde, Berciano, María T., González-Sancho, José Manuel, Caelles, Carme, Lafarga, Miguel, Muñoz, Alberto |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175250/ https://www.ncbi.nlm.nih.gov/pubmed/10974006 |
Ejemplares similares
-
Glucocorticoid Resistance: Interference between the Glucocorticoid Receptor and the MAPK Signalling Pathways
por: Sevilla, Lisa M., et al.
Publicado: (2021) -
Distinct Responses to IL4 in Macrophages Mediated by JNK
por: Arpa, Luís, et al.
Publicado: (2023) -
JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3
por: Sunayama, Jun, et al.
Publicado: (2005) -
Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1
por: Liu, Li, et al.
Publicado: (2017) -
In Vivo JNK Activation in Pancreatic β-Cells Leads to Glucose Intolerance Caused by Insulin Resistance in Pancreas
por: Lanuza-Masdeu, Jordi, et al.
Publicado: (2013)